Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Ibandronate-Sodium Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Ibandronate Sodium Manufacturers in India Suppliers Ibandronate Sodium Exporters Distributors Ibandronate Sodium api active pharmaceuticals ingredients Ibandronate Sodium manufacturers Side Effects bulk drugs raw material Ibandronate Sodium companies Side Effects Importers Ibandronate Sodium Ibandronate Sodium Exporters Ibandronate Sodium exporters FDA Ibandronate Sodium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Ibandronate Sodium manufacturing pharmaceutical drugs pharmaceutical intermediates Ibandronate Sodium pharmaceutical chemicals pharmaceutical raw materials Ibandronate Sodium active pharmaceutical ingredients Ibandronate Sodium committee active pharmaceutical ingredients manufacturer Ibandronate Sodium Active Pharmaceutical Ingredients manufacturer Ibandronate Sodium exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Ibandronate Sodium, Ibandronate Sodium manufacturer India, Ibandronate Sodium product, Ibandronate Sodium products, Api preparation, Certificate of Analysis API manufacturer product, Ibandronate Sodium anti ulcer product, Certificate of Origin COA Ibandronate Sodium COS Ibandronate Sodium, pharmaceutical generic, pharmaceutical drug, medical, Ibandronate Sodium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ibandronate Sodium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ibandronate Sodium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ibandronate Sodium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ibandronate Sodium ingredients, api, HIV Ibandronate Sodium, tablets, capsules, syrup & protein Ibandronate Sodium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ibandronate Sodium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ibandronate Sodium WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image Ibandronate Sodium











 


 







 

 

HOME >> API >> API List 2 >> Ibandronate Sodium >> Consumer Information

Ibandronate Sodium CAS Number 138926-19-9

CONSUMER INFORMATION
 
CAS Number 138926-19-9

USES: Ibandronate is used to prevent and treat certain types of bone loss (osteoporosis). Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause, as you age,Take this medication by mouth usually once a day, or as directed by your doctor. Take this medication after getting up for the day, before taking your first food, beverage or other medication. Do not take it at bedtime or while you are still in bed. SIDE EFFECTS: Stomach upset, diarrhea, pain in arms/legs, or mild flu-like symptoms (e.g., fatigue, muscle ache) may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

PRECAUTIONS: Before taking ibandronate, tell your doctor or pharmacist if you are allergic to it; or to other bisphosphonates (e.g., alendronate, etidronate, pamidronate, risedronate); or if you have any other allergies.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have the following conditions: low blood calcium levels (hypocalcemia), inability to sit upright or stand for 60 minutes, severe kidney disease.
MISSED DOSE: If you miss a dose, do not take it later in the day. Take the medication the next morning after you remember. Do not take two tablets on the same day to catch up. Consult your doctor or pharmacist if you have any questions. STORAGE: Store at room temperature at 77 degrees F (25 degrees C) away from light and moisture. Brief storage between 59-86 degrees F (15-30 degrees C) is permitted. Do not store in the bathroom. Keep all medicines away from children

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION >>
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Ibandronate Sodium

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.